🇺🇸 Lauromacrogol in United States
117 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 117
Most-reported reactions
- Diarrhoea — 15 reports (12.82%)
- Fatigue — 15 reports (12.82%)
- Insomnia — 12 reports (10.26%)
- Candida Infection — 11 reports (9.4%)
- Cough — 11 reports (9.4%)
- Embolism — 11 reports (9.4%)
- Hyperglycaemia — 11 reports (9.4%)
- Oropharyngeal Pain — 11 reports (9.4%)
- Thrombosis — 11 reports (9.4%)
- Genital Herpes — 9 reports (7.69%)
Other Other approved in United States
Frequently asked questions
Is Lauromacrogol approved in United States?
Lauromacrogol does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Lauromacrogol in United States?
Shanghai Zhongshan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.